Login

Healthcare

00:00:00
Cellmid Limited to supply rapid diagnostic tests to help - Maria Halasz, CEO, Cellmid Ltd
00:00:00
Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value - Jim Martin, Co-CEO and CFO, Cocrystal Pharma, Inc.
00:00:00
Cogstate Limited - Brad O’Connor Chief Executive Officer, CogState Ltd
00:00:00
Collagen Solutions Overview - Jamal Rushdy, Chief Executive Office, Collagen Solutions
00:00:00
Collagen Solutions released financial number showing more strong sales numbers - Jamal Rushdy, Chief Executive Office, Collagen Solutions
00:00:00
Bond repayment amendment to give Collagen Solutions 'greater flexibility to exploit opportunities' -Jamal Rushdy, Chief Executive Office, Collagen Solutions
00:00:00
ollagen Solutions 'well on track' with plans for CE Mark and first surgery - Jamal Rushdy, Chief Executive Office, Collagen Solutions
00:00:00
Collagen Solutions applies for European approval after successful ChondroMimetic study -Jamal Rushdy, Chief Executive Office, Collagen Solutions
00:00:00
Compumedics expects to be back in profit for FY23 - David Lawson, CFO, Compumedics Ltd
00:00:00
David Cutler CEO, Centric Health Corporation
00:00:00
Corline Biomedical - Naventus Healthcare Summit, May 10, 2022 - Henrik Nittmar, CEO at Corline Biomedical
00:00:00
Olivier Giré, Chief Operating Officer Specialty Pharma, Crossject
00:00:00
Oliver Schacht, CEO, Curetis
00:00:00
Innovative Targeted Therapies for Advanced Cancer - Spiro Rombotis, CEO, Cyclacel Pharmaceuticals
00:00:00
Cynata Therapeutics (ASX:CYP) CEO & MD Kilian Kelly
00:00:00
Dedicare - ABGSC Investor Days 8 mars 2022 - Krister Widstrom, CEO, Dedicare AB (publ)

© 2017 - Townhall + Tv